Hyderabad: Granules India Ltd gets ANDA approval

0

Hyderabad: Granules India Limited announced on Monday that the US Food & Drug Administration (US FDA) has approved it’s Abbreviated New Drug Application (ANDA) for losartan potassium tablets. This will take their tally to a total of 54 ANDA approvals from the US FDA.

Losartan potassium tablets are used for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure.

According to Medication-assisted treatment (MAT), the current annual U.S. market for losartan potassium tablets is approximately $336 million

“Granules India Limited has consistently achieved manufacturing success, set new standards of quality, and expanded its presence across the world,” a press release said.

Subscribe us on The Siasat Daily - Google News

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health & Fitness News Click Here 

Read original article here

Denial of responsibility! Rapidtelecast.com is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
Leave a comment